Non-invasive imaging of angiogenesis in head and neck squamous cell carcinoma

Angiogenesis

Volumn 13, Issue 2, 2010, Pages 149-160

  Jansen, Jacobus F A ^a   Koutcher, Jason A ^a   Shukla Dave, Amita ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Angiogenesis; Anti angiogenic treatment; Computed tomography; Head and neck squamous cell carcinoma; Imaging techniques; Magnetic resonance imaging; Molecular imaging; Positron emission tomography; Ultrasound

Indexed keywords

1 FLUORO 3 (2 NITRO 1 IMIDAZOLYL) 2 PROPANOL F 18; 3' FLUOROTHYMIDINE F 18; ANTINEOPLASTIC AGENT; ARGINYLGLYCYLASPARTIC ACID; BEVACIZUMAB; CREATINE PHOSPHATE; GADOLINIUM PENTETATE; NUCLEOSIDE TRIPHOSPHATE; PHOSPHATE; PHOSPHOETHANOLAMINE; PHOSPHORYLCHOLINE; SEMAXANIB; SORAFENIB; SUNITINIB; TRANSFERRIN RECEPTOR; VASCULOTROPIN; VITRONECTIN RECEPTOR;

ANTIANGIOGENIC ACTIVITY; BLOOD FLOW; BLOOD VOLUME; CANCER RADIOTHERAPY; CANCER SURVIVAL; CERVICAL LYMPH NODE; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; DIFFUSION WEIGHTED IMAGING; ECHOGRAPHY; HEAD AND NECK CARCINOMA; HEAD AND NECK SURGERY; HUMAN; LYMPH NODE METASTASIS; METASTASIS POTENTIAL; NON INVASIVE MEASUREMENT; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SQUAMOUS CELL CARCINOMA; TUMOR GROWTH; TUMOR VASCULARIZATION;

ANIMALS; CARCINOMA, SQUAMOUS CELL; DIAGNOSTIC IMAGING; HEAD AND NECK NEOPLASMS; HUMANS; NEOVASCULARIZATION, PATHOLOGIC;

EID: 77955628017     PISSN: 09696970     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10456-010-9167-z     Document Type: Review

References (85)

1. A Jemal R Siegel E Ward Y Hao J Xu MJ Thun 2009 Cancer statistics, 2009 CA Cancer J Clin 59 225 249 10.3322/caac.20006 19474385
2. EE Vokes RR Weichselbaum SM Lippman WK Hong 1993 Head and neck cancer N Engl J Med 328 184 194 10.1056/NEJM199301213280306 8417385 (Pubitemid 23021505)
3. ML Klem JG Mechalakos SL Wolden MJ Zelefsky B Singh D Kraus A Shaha J Shah DG Pfister NY Lee 2008 Intensity-modulated radiotherapy for head and neck cancer of unknown primary: toxicity and preliminary efficacy Int J Radiat Oncol Biol Phys 70 1100 1107 17980501
4. NY Lee W O'Meara K Chan C Della-Bianca JG Mechalakos J Zhung SL Wolden A Narayana D Kraus JP Shah DG Pfister 2007 Concurrent chemotherapy and intensity-modulated radiotherapy for locoregionally advanced laryngeal and hypopharyngeal cancers Int J Radiat Oncol Biol Phys 69 459 468 17493769
5. LH Schwartz M Ozsahin GN Zhang E Touboul F De Vataire P Andolenko J Lacau-Saint-Guily A Laugier M Schlienger 1994 Synchronous and metachronous head and neck carcinomas Cancer 74 1933 1938 10.1002/1097-0142(19941001)74:7<1933: :AID-CNCR2820740718>3.0.CO;2-X 8082099 (Pubitemid 24301857)
6. GL Day WJ Blot 1992 Second primary tumors in patients with oral cancer Cancer 70 14 19 10.1002/1097-0142(19920701)70:1<14::AID-CNCR2820700103>3. 0.CO;2-S 1606536
7. P Carmeliet RK Jain 2000 Angiogenesis in cancer and other diseases Nature 407 249 257 10.1038/35025220 11001068
8. TY Seiwert EE Cohen 2008 Targeting angiogenesis in head and neck cancer Semin Oncol 35 274 285 10.1053/j.seminoncol.2008.03.005 18544442 (Pubitemid 351787696)
9. KT Palka RJ Slebos CH Chung 2008 Update on molecular diagnostic tests in head and neck cancer Semin Oncol 35 198 210 10.1053/j.seminoncol.2008.03.002 18544435 (Pubitemid 351787692)
10. N Weidner J Folkman F Pozza P Bevilacqua EN Allred DH Moore S Meli G Gasparini 1992 Tumor angiogenesis: a new significant and independent prognostic indicator in early-stage breast carcinoma J Natl Cancer Inst 84 1875 1887 10.1093/jnci/84.24.1875 1281237
11. M Mendiola J Barriuso A Redondo A Marino-Enriquez R Madero E Espinosa JA Vara I Sanchez-Navarro G Hernandez-Cortes P Zamora E Perez-Fernandez M Miguel-Martin A Suarez J Palacios M Gonzalez-Baron D Hardisson 2008 Angiogenesis-related gene expression profile with independent prognostic value in advanced ovarian carcinoma PLoS One 3 e4051 10.1371/journal.pone.0004051 19112514
12. CA Angeletti M Lucchi G Fontanini A Mussi A Chella A Ribechini S Vignati G Bevilacqua 1996 Prognostic significance of tumoral angiogenesis in completely resected late stage lung carcinoma (stage IIIA-N2). Impact of adjuvant therapies in a subset of patients at high risk of recurrence Cancer 78 409 415 10.1002/(SICI)1097-0142(19960801)78:3<409::AID-CNCR5>3.0.CO;2-E 8697384 (Pubitemid 26250524)
13. Y Ito T Kamijo T Yokose M Kawashima T Ogino H Ikeda R Hayashi S Sasaki A Ochiai 2001 Microvessel density predicts the radiosensitivity of metastatic head and neck squamous cell carcinoma in cervical lymph nodes Int J Oncol 19 1127 1132 11713580
14. ER Sauter M Nesbit JC Watson A Klein-Szanto S Litwin M Herlyn 1999 Vascular endothelial growth factor is a marker of tumor invasion and metastasis in squamous cell carcinomas of the head and neck Clin Cancer Res 5 775 782 10213212
15. L Pignataro N Carboni V Midolo F Bertolini R Buffa BM Cesana A Neri G Viale G Pruneri 2001 Clinical relevance of microvessel density in laryngeal squamous cell carcinomas Int J Cancer 92 666 670 10.1002/1097-0215(20010601)92: 5<666::AID-IJC1239>3.0.CO;2-Y 11340569 (Pubitemid 32385707)
16. RK Jain DG Duda CG Willett DV Sahani AX Zhu JS Loeffler TT Batchelor AG Sorensen 2009 Biomarkers of response and resistance to antiangiogenic therapy Nat Rev Clin Oncol 6 327 338 10.1038/nrclinonc.2009.63 19483739
17. B Turkbey H Kobayashi M Ogawa M Bernardo PL Choyke 2009 Imaging of tumor angiogenesis: functional or targeted? AJR Am J Roentgenol 193 304 313 10.2214/AJR.09.2869 19620425
18. N Charnley S Donaldson P Price 2009 Imaging angiogenesis Methods Mol Biol 467 25 51 10.1007/978-1-59745-241-0-2 19301663
19. L Faggioni E Neri C Bartolozzi 2010 CT perfusion of head and neck tumors: how we do it AJR Am J Roentgenol 194 62 69 10.2214/AJR.09.3187 20028906
20. FG Aksoy MH Lev 2000 Dynamic contrast-enhanced brain perfusion imaging: technique and clinical applications Semin Ultrasound CT MR 21 462 477 10.1016/S0887-2171(00)90038-6 11138635
21. GV Shah JR Wesolowski SA Ansari SK Mukherji 2008 New directions in head and neck imaging J Surg Oncol 97 644 648 10.1002/jso.21022 18493943 (Pubitemid 351812963)
22. D Gandhi EG Hoeffner RC Carlos I Case SK Mukherji 2003 Computed tomography perfusion of squamous cell carcinoma of the upper aerodigestive tract. Initial results J Comput Assist Tomogr 27 687 693 10.1097/00004728- 200309000-00005 14501359 (Pubitemid 37087737)
23. R Hermans M Meijerink W Van den Bogaert A Rijnders C Weltens P Lambin 2003 Tumor perfusion rate determined noninvasively by dynamic computed tomography predicts outcome in head-and-neck cancer after radiotherapy Int J Radiat Oncol Biol Phys 57 1351 1356 14630273
24. D Gandhi DB Chepeha T Miller RC Carlos CR Bradford R Karamchandani F Worden A Eisbruch TN Teknos GT Wolf SK Mukherji 2006 Correlation between initial and early follow-up CT perfusion parameters with endoscopic tumor response in patients with advanced squamous cell carcinomas of the oropharynx treated with organ-preservation therapy AJNR Am J Neuroradiol 27 101 106 16418366
25. A Zima R Carlos D Gandhi I Case T Teknos SK Mukherji 2007 Can pretreatment CT perfusion predict response of advanced squamous cell carcinoma of the upper aerodigestive tract treated with induction chemotherapy? AJNR Am J Neuroradiol 28 328 334 17297007
26. L Ash TN Teknos D Gandhi S Patel SK Mukherji 2009 Head and neck squamous cell carcinoma: CT perfusion can help noninvasively predict intratumoral microvessel density Radiology 251 422 428 10.1148/radiol.2512080743 19276321
27. N Hylton 2006 Dynamic contrast-enhanced magnetic resonance imaging as an imaging biomarker J Clin Oncol 24 3293 3298 10.1200/JCO.2006.06.8080 16829653 (Pubitemid 46622069)
28. TE Yankeelov JC Gore 2007 Dynamic contrast enhanced magnetic resonance imaging in oncology: theory, data acquisition, analysis and examples Curr Med Imaging Rev 3 91 107 10.2174/157340507780619179 (Pubitemid 46773870)
29. H Konouchi J Asaumi Y Yanagi H Shigehara M Hisatomi H Matsuzaki K Kishi 2003 Evaluation of tumor proliferation using dynamic contrast enhanced-MRI of oral cavity and oropharyngeal squamous cell carcinoma Oral Oncol 39 290 295 10.1016/S1368-8375(02)00119-7 12618202 (Pubitemid 36255696)
30. PJ Hoskin MI Saunders K Goodchild ME Powell NJ Taylor H Baddeley 1999 Dynamic contrast enhanced magnetic resonance scanning as a predictor of response to accelerated radiotherapy for advanced head and neck cancer Br J Radiol 72 1093 1098 10700827
31. Y Cao A Popovtzer D Li DB Chepeha JS Moyer ME Prince F Worden T Teknos C Bradford SK Mukherji A Eisbruch 2008 Early prediction of outcome in advanced head-and-neck cancer based on tumor blood volume alterations during therapy: a prospective study Int J Radiat Oncol Biol Phys 72 1287 1290 19028268
32. S Kim LA Loevner H Quon A Kilger E Sherman G Weinstein A Chalian H Poptani 2010 Prediction of response to chemoradiation therapy in squamous cell carcinomas of the head and neck using dynamic contrast-enhanced MR imaging AJNR Am J Neuroradiol 31 262 268 10.3174/ajnr.A1817 19797785
33. DM Koh DJ Collins 2007 Diffusion-weighted MRI in the body: applications and challenges in oncology AJR Am J Roentgenol 188 1622 1635 10.2214/AJR.06.1403 17515386 (Pubitemid 46866868)
34. AA Abdel Razek G Gaballa G Elhawarey AS Megahed M Hafez N Nada 2009 Characterization of pediatric head and neck masses with diffusion-weighted MR imaging Eur Radiol 19 201 208 10.1007/s00330-008-1123-6 18704436
35. J Wang S Takashima F Takayama S Kawakami A Saito T Matsushita M Momose T Ishiyama 2001 Head and neck lesions: characterization with diffusion-weighted echo-planar MR imaging Radiology 220 621 630 10.1148/radiol.2202010063 11526259
36. M Sumi T Nakamura 2009 Diagnostic importance of focal defects in the apparent diffusion coefficient-based differentiation between lymphoma and squamous cell carcinoma nodes in the neck Eur Radiol 19 975 981 10.1007/s00330-008-1217-1 18958472
37. AA Abdel Razek AS Megahed A Denewer A Motamed A Tawfik N Nada 2008 Role of diffusion-weighted magnetic resonance imaging in differentiation between the viable and necrotic parts of head and neck tumors Acta Radiol 49 364 370 10.1080/02841850701777390
38. V Vandecaveye F de Keyzer V Vander Poorten K Deraedt H Alaerts W Landuyt S Nuyts R Hermans 2006 Evaluation of the larynx for tumour recurrence by diffusion-weighted MRI after radiotherapy: initial experience in four cases Br J Radiol 79 681 687 10.1259/bjr/89661809 16641411 (Pubitemid 44283158)
39. M Maeda H Kato H Sakuma SE Maier K Takeda 2005 Usefulness of the apparent diffusion coefficient in line scan diffusion-weighted imaging for distinguishing between squamous cell carcinomas and malignant lymphomas of the head and neck AJNR Am J Neuroradiol 26 1186 1192 15891182
40. A Srinivasan R Dvorak K Perni S Rohrer SK Mukherji 2008 Differentiation of benign and malignant pathology in the head and neck using 3T apparent diffusion coefficient values: early experience AJNR Am J Neuroradiol 29 40 44 10.3174/ajnr.A0743 17921228
41. JF Jansen HE Stambuk JA Koutcher A Shukla-Dave 2009 Non-Gaussian analysis of diffusion-weighted MR imaging in head and neck squamous cell carcinoma: a feasibility study AJNR Am J Neuroradiol 10.3174/ajnr.A1919
42. DM Koh M Blackledge DJ Collins AR Padhani T Wallace B Wilton NJ Taylor JJ Stirling R Sinha P Walicke MO Leach I Judson P Nathan 2009 Reproducibility and changes in the apparent diffusion coefficients of solid tumours treated with combretastatin A4 phosphate and bevacizumab in a two-centre phase I clinical trial Eur Radiol 19 2728 2738 10.1007/s00330-009-1469-4 19547986
43. JG Liu B Wang XZ Wang QL Niu Q Zhang 2009 Diffusion weighted MRI helps evaluate angiogenesis and vascular endothelial growth factor expression in prostate cancer Zhonghua Nan Ke Xue 15 403 408 19514550
44. P Dirix F De Keyzer V Vandecaveye S Stroobants R Hermans S Nuyts 2008 Diffusion-weighted magnetic resonance imaging to evaluate major salivary gland function before and after radiotherapy Int J Radiat Oncol Biol Phys 71 1365 1371 18355977
45. S Kim L Loevner H Quon E Sherman G Weinstein A Kilger H Poptani 2009 Diffusion-weighted magnetic resonance imaging for predicting and detecting early response to chemoradiation therapy of squamous cell carcinomas of the head and neck Clin Cancer Res 15 986 994 10.1158/1078-0432.CCR-08-1287 19188170
46. CJ Galban SK Mukherji TL Chenevert CR Meyer DA Hamstra PH Bland TD Johnson BA Moffat A Rehemtulla A Eisbruch BD Ross 2009 A feasibility study of parametric response map analysis of diffusion-weighted magnetic resonance imaging scans of head and neck cancer patients for providing early detection of therapeutic efficacy Transl Oncol 2 184 190 19701503
47. JF Jansen WH Backes K Nicolay ME Kooi 2006 1H MR spectroscopy of the brain: absolute quantification of metabolites Radiology 240 318 332 10.1148/radiol.2402050314 16864664 (Pubitemid 44098628)
48. GV Shah D Gandhi SK Mukherji 2004 Magnetic resonance spectroscopy of head and neck neoplasms Top Magn Reson Imaging 15 87 94 10.1097/01.rmr.0000130599. 19502.ba 15269611 (Pubitemid 38987407)
49. SB Thakur J Yaligar JA Koutcher 2009 In vivo lactate signal enhancement using binomial spectral-selective pulses in selective MQ coherence (SS-SelMQC) spectroscopy Magn Reson Med 62 591 598 10.1002/mrm.22065 19526486
50. S Chawla S Kim LA Loevner H Quon S Wang F Mutale G Weinstein EJ Delikatny H Poptani 2009 Proton and phosphorous MR spectroscopy in squamous cell carcinomas of the head and neck Acad Radiol 16 1366 1372 10.1016/j.acra.2009.06. 001 19608433
51. A Shukla-Dave H Poptani LA Loevner A Mancuso H Serrai DI Rosenthal AM Kilger DS Nelson KL Zakian F Arias-Mendoza M Rijpkema JA Koutcher TR Brown A Heerschap JD Glickson 2002 Prediction of treatment response of head and neck cancers with P-31 MR spectroscopy from pretreatment relative phosphomonoester levels Acad Radiol 9 688 694 10.1016/S1076-6332(03)80314-8 12061743 (Pubitemid 34568804)
52. EO Aboagye ZM Bhujwalla 1999 Malignant transformation alters membrane choline phospholipid metabolism of human mammary epithelial cells Cancer Res 59 80 84 9892190
53. J Star-Lack D Spielman E Adalsteinsson J Kurhanewicz DJ Terris DB Vigneron 1998 In vivo lactate editing with simultaneous detection of choline, creatine, NAA, and lipid singlets at 1.5 T using PRESS excitation with applications to the study of brain and head and neck tumors J Magn Reson 133 243 254 10.1006/jmre.1998.1458 9716465
54. JM Star-Lack E Adalsteinsson MF Adam DJ Terris HA Pinto JM Brown DM Spielman 2000 In vivo 1H MR spectroscopy of human head and neck lymph node metastasis and comparison with oxygen tension measurements AJNR Am J Neuroradiol 21 183 193 10669248
55. H Schoder M Fury N Lee D Kraus 2009 PET monitoring of therapy response in head and neck squamous cell carcinoma J Nucl Med 50 Suppl 1 74S 88S 10.2967/jnumed.108.057208 19380408
56. AJ Beer R Haubner I Wolf M Goebel S Luderschmidt M Niemeyer AL Grosu MJ Martinez HJ Wester WA Weber M Schwaiger 2006 PET-based human dosimetry of 18F-galacto-RGD, a new radiotracer for imaging alpha v beta3 expression J Nucl Med 47 763 769 16644745
57. AJ Beer AL Grosu J Carlsen A Kolk M Sarbia I Stangier P Watzlowik HJ Wester R Haubner M Schwaiger 2007 [18F]galacto-RGD positron emission tomography for imaging of alphavbeta3 expression on the neovasculature in patients with squamous cell carcinoma of the head and neck Clin Cancer Res 13 6610 6616 10.1158/1078-0432.CCR-07-0528 18006761 (Pubitemid 350206795)
58. NY Lee JG Mechalakos S Nehmeh Z Lin OD Squire S Cai K Chan PB Zanzonico C Greco CC Ling JL Humm H Schoder 2008 Fluorine-18-labeled fluoromisonidazole positron emission and computed tomography-guided intensity-modulated radiotherapy for head and neck cancer: a feasibility study Int J Radiat Oncol Biol Phys 70 2 13 17869020
59. JS Rasey WJ Koh ML Evans LM Peterson TK Lewellen MM Graham KA Krohn 1996 Quantifying regional hypoxia in human tumors with positron emission tomography of [18F]fluoromisonidazole: a pretherapy study of 37 patients Int J Radiat Oncol Biol Phys 36 417 428 8892467
60. DM Brizel RK Dodge RW Clough MW Dewhirst 1999 Oxygenation of head and neck cancer: changes during radiotherapy and impact on treatment outcome Radiother Oncol 53 113 117 10.1016/S0167-8140(99)00102-4 10665787
61. M Nordsmark SM Bentzen V Rudat D Brizel E Lartigau P Stadler A Becker M Adam M Molls J Dunst DJ Terris J Overgaard 2005 Prognostic value of tumor oxygenation in 397 head and neck tumors after primary radiation therapy. An international multi-center study Radiother Oncol 77 18 24 10.1016/j.radonc.2005. 06.038 16098619 (Pubitemid 41503384)
62. JF Jansen H Schöder NY Lee Y Wang DG Pfister MG Fury HE Stambuk JL Humm JA Koutcher A Shukla-Dave 2009 Noninvasive assessment of tumor microenvironment using dynamic contrast-enhanced magnetic resonance imaging and (18)F-fluoromisonidazole positron emission tomography imaging in neck nodal metastases Int J Radiat Oncol Biol Phys 10.1016/j.ijrobp.2009.07.009
63. H Barthel MC Cleij DR Collingridge OC Hutchinson S Osman Q He SK Luthra F Brady PM Price EO Aboagye 2003 3′-deoxy-3′-[18F]fluorothymidine as a new marker for monitoring tumor response to antiproliferative therapy in vivo with positron emission tomography Cancer Res 63 3791 3798 12839975
64. DC Cobben BF van der Laan B Maas W Vaalburg AJ Suurmeijer HJ Hoekstra PL Jager PH Elsinga 2004 18F-FLT PET for visualization of laryngeal cancer: comparison with 18F-FDG PET J Nucl Med 45 226 231 14960640
65. A Linecker C Kermer I Sulzbacher P Angelberger K Kletter R Dudczak R Ewers A Becherer 2008 Uptake of (18)F-FLT and (18)F-FDG in primary head and neck cancer correlates with survival Nuklearmedizin 47 80 85 18392317 (quiz N12)
66. PS Richards TE Peacock 2007 The role of ultrasound in the detection of cervical lymph node metastases in clinically N0 squamous cell carcinoma of the head and neck Cancer Imaging 7 167 178 10.1102/1470-7330.2007.0024 18055290
67. A Jacob BE Varghese MB Birchall 2006 Validation of laser Doppler fluxmetry as a method of assessing neo-angiogenesis in laryngeal tumours Eur Arch Otorhinolaryngol 263 444 448 10.1007/s00405-005-1020-4 16311774 (Pubitemid 43800564)
68. TF Massoud SS Gambhir 2003 Molecular imaging in living subjects: seeing fundamental biological processes in a new light Genes Dev 17 545 580 10.1101/gad.1047403 12629038 (Pubitemid 36307540)
69. R Weissleder U Mahmood 2001 Molecular imaging Radiology 219 316 333 11323453
70. P Winnard Jr V Raman 2003 Real time non-invasive imaging of receptor-ligand interactions in vivo J Cell Biochem 90 454 463 10.1002/jcb.10616 14523979 (Pubitemid 37243692)
71. TR Daniels T Delgado G Helguera ML Penichet 2006 The transferrin receptor part II: targeted delivery of therapeutic agents into cancer cells Clin Immunol 121 159 176 10.1016/j.clim.2006.06.006 16920030 (Pubitemid 44572972)
72. JH Kearsley KL Furlong RA Cooke MJ Waters 1990 An immunohistochemical assessment of cellular proliferation markers in head and neck squamous cell cancers Br J Cancer 61 821 827 2372483
73. L Shan Y Hao S Wang A Korotcov R Zhang T Wang J Califano X Gu R Sridhar ZM Bhujwalla PC Wang 2008 Visualizing head and neck tumors in vivo using near-infrared fluorescent transferrin conjugate Mol Imaging 7 42 49 18384723
74. Y Liu H Miyoshi M Nakamura 2007 Nanomedicine for drug delivery and imaging: a promising avenue for cancer therapy and diagnosis using targeted functional nanoparticles Int J Cancer 120 2527 2537 10.1002/ijc.22709 17390371 (Pubitemid 46651272)
75. W Cai X Chen 2008 Multimodality molecular imaging of tumor angiogenesis J Nucl Med 49 Suppl 2 113S 128S 10.2967/jnumed.107.045922 18523069 (Pubitemid 351948040)
76. DM Cognetti RS Weber SY Lai 2008 Head and neck cancer: an evolving treatment paradigm Cancer 113 1911 1932 10.1002/cncr.23654 18798532
77. JP Machiels S Henry S Zanetta MC Kaminsky N Michoux D Rommel S Schmitz E Bompas AF Dillies S Faivre A Moxhon T Duprez J Guigay 2010 Phase II study of sunitinib in recurrent or metastatic squamous cell carcinoma of the head and neck: GORTEC 2006-01 J Clin Oncol 28 21 28 10.1200/JCO.2009.23.8584 19917865
78. MG Fury A Zahalsky R Wong E Venkatraman E Lis L Hann T Aliff W Gerald M Fleisher DG Pfister 2007 A phase II study of SU5416 in patients with advanced or recurrent head and neck cancers Invest New Drugs 25 165 172 10.1007/s10637-006-9011-x 16983506 (Pubitemid 46020876)
79. ER Gerstner DG Duda E di Tomaso PA Ryg JS Loeffler AG Sorensen P Ivy RK Jain TT Batchelor 2009 VEGF inhibitors in the treatment of cerebral edema in patients with brain cancer Nat Rev Clin Oncol 6 229 236 10.1038/nrclinonc.2009. 14 19333229
80. XM Zhang D Yu HL Zhang Y Dai D Bi Z Liu MR Prince C Li 2008 3D dynamic contrast-enhanced MRI of rectal carcinoma at 3T: correlation with microvascular density and vascular endothelial growth factor markers of tumor angiogenesis J Magn Reson Imaging 27 1309 1316 10.1002/jmri.21378 18504761 (Pubitemid 351770682)
81. L Shiyan H Pintong W Zongmin H Fuguang Z Zhiqiang Y Yan D Cosgrove 2009 The relationship between enhanced intensity and microvessel density of gastric carcinoma using double contrast-enhanced ultrasonography Ultrasound Med Biol 35 1086 1091 10.1016/j.ultrasmedbio.2009.03.010 19419811
82. J Guo K Higashi Y Ueda M Oguchi T Takegami H Toga T Sakuma H Yokota S Katsuda H Tonami I Yamamoto 2006 Microvessel density: correlation with 18F-FDG uptake and prognostic impact in lung adenocarcinomas J Nucl Med 47 419 425 16513610
83. N Lawrentschuk AM Poon SS Foo LG Putra C Murone ID Davis DM Bolton AM Scott 2005 Assessing regional hypoxia in human renal tumours using 18F-fluoromisonidazole positron emission tomography BJU Int 96 540 546 10.1111/j.1464-410X.2005.05681.x 16104907 (Pubitemid 41224324)
84. RK Jain 2005 Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy Science 307 58 62 10.1126/science.1104819 15637262 (Pubitemid 40093472)
85. M Oostendorp MJ Post WH Backes 2009 Vessel growth and function: depiction with contrast-enhanced MR imaging Radiology 251 317 335 10.1148/radiol. 2512080485 19401568